Article thumbnail

Whole-Genome Immunoinformatic Analysis of F. tularensis: Predicted CTL Epitopes Clustered in Hotspots Are Prone to Elicit a T-Cell Response

By Anat Zvi, Shahar Rotem, Erez Bar-Haim, Ofer Cohen and Avigdor Shafferman

Abstract

The cellular arm of the immune response plays a central role in the defense against intracellular pathogens, such as F. tularensis. To date, whole genome immunoinformatic analyses were limited either to relatively small genomes (e.g. viral) or to preselected subsets of proteins in complex pathogens. Here we present, for the first time, an unbiased bacterial global immunoinformatic screen of the 1740 proteins of F. tularensis subs. holarctica (LVS), aiming at identification of immunogenic peptides eliciting a CTL response. The very large number of predicted MHC class I binders (about 100,000, IC50 of 1000 nM or less) required the design of a strategy for further down selection of CTL candidates. The approach developed focused on mapping clusters rich in overlapping predicted epitopes, and ranking these “hotspot” regions according to the density of putative binding epitopes. Limited by the experimental load, we selected to screen a library of 1240 putative MHC binders derived from 104 top-ranking highly dense clusters. Peptides were tested for their ability to stimulate IFNγ secretion from splenocytes isolated from LVS vaccinated C57BL/6 mice. The majority of the clusters contained one or more CTL responder peptides and altogether 127 novel epitopes were identified, of which 82 are non-redundant. Accordingly, the level of success in identification of positive CTL responders was 17–25 fold higher than that found for a randomly selected library of 500 predicted MHC binders (IC50 of 500 nM or less). Most proteins (ca. 2/3) harboring the highly dense hotspots are membrane-associated. The approach for enrichment of true positive CTL epitopes described in this study, which allowed for over 50% increase in the dataset of known T-cell epitopes of F. tularensis, could be applied in immunoinformatic analyses of many other complex pathogen genomes

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3098878
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2006). A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus.
  2. (1982). A simple method for displaying the hydropathic character of a protein.
  3. (2000). Application of genomics and proteomics for identification of bacterial gene products as potential vaccine candidates.
  4. (2003). Clustering of Th cell epitopes on exposed regions of HIV envelope despite defects in antibody activity.
  5. (2002). Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.
  6. (2003). Differential proteasomal processing of hydrophobic and hydrophilic protein regions: contribution to cytotoxic T lymphocyte epitope clustering in HIV-1-Nef.
  7. (2007). Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
  8. (2007). Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen.
  9. (2001). Epitope clusters in the major outer membrane protein of Chlamydia trachomatis.
  10. (2007). Epitopedriven TB vaccine development: a streamlined approach using immunoinformatics, ELISpot assays, and HLA transgenic mice.
  11. (2008). Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research.
  12. (2008). Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research.
  13. (2007). Francisella tularensis genomics and proteomics.
  14. (2009). Francisella tularensis vaccines.
  15. (2002). Genomic approach for analysis of surface proteins in Chlamydia pneumoniae.
  16. (2005). Identification of a universal Group B streptococcus vaccine by multiple genome screen.
  17. (2008). Identification of genome-derived vaccine candidates conserved between human and mouseadapted strains of H.
  18. (2001). Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis.
  19. (2000). Identification of vaccine candidates against serogroup B meningococcus by wholegenome sequencing.
  20. (2003). Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors.
  21. (1999). Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.
  22. (2004). Improved prediction of signal peptides:
  23. (2006). Intracellular survival mechanisms of Francisella tularensis,a stealth pathogen.
  24. (2007). Largescale validation of methods for cytotoxic T-lymphocyte epitope prediction.
  25. (2001). Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing.
  26. (2010). Major histocompatibility complex class I binding predictions as a tool in epitope discovery.
  27. (2010). MHC class II epitope predictive algorithms.
  28. (2008). NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11.
  29. (2008). Precise score for the prediction of peptides cleaved by the proteasome.
  30. (2001). Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.
  31. (2006). Protective immunity towards intracellular pathogens.
  32. (2009). Rationally designed tularemia vaccines.
  33. (2010). Reverse vaccinology in Bacillus anthracis. In: The challenge of highly pathogenic microorganisms - mechanism of virulence and novel medical countermeasures Shafferman
  34. (2009). Sette A
  35. (2008). Shafferman A
  36. Sjostedt A (2010) Novel live vaccine candidates against airborne Francisella tularensis. In: The challenge of highly pathogenic microorganisms -mechanism of virulence and novel medical countermeasures Shafferman
  37. (2010). State of the art and challenges in sequence based T-cell epitope prediction.
  38. (1999). SYFPEITHI: database for MHC ligands and peptide motifs.
  39. (2009). The distribution of CTL epitopes in HIV-1 appears to be random, and similar to that of other proteomes.
  40. (2010). The immune epitope database 2.0.
  41. (1994). The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
  42. (2005). The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage.
  43. (2009). The use of genomics in microbial vaccine development.
  44. (2006). The validity of predicted T-cell epitopes.
  45. (1996). Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes.
  46. (2007). Tularemia vaccines -an overview.
  47. (2008). Tularemia: current diagnosis and treatment options.
  48. (2001). Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection.
  49. (2007). Vaccines against Francisella tularensis.
  50. (2008). Vaccines against intracellular bacterial pathogens.
  51. (2000). Vaccines against intracellular infections requiring cellular immunity.
  52. (2009). Vaccines against tularemia.
  53. (2007). Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses.
  54. (2009). Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.
  55. (2010). Zajac AJ (2010) Shaping successful and unsuccessful CD8 T cell responses following infection.